Cwm LLC Sells 8,389 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)
Cwm LLC Sells 8,389 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)
In other Axon Enterprise news, Director Mark W. Kroll sold 3,159 shares of the firm's stock in a transaction dated Wednesday, June 8th. The shares were sold at an average price of $102.82, for a total value of $324,808.38. Following the completion of the sale, the director now owns 13,691 shares of the company's stock, valued at $1,407,708.62. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 6.90% of the stock is owned by company insiders. Cwm LLC cut its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 57.2% during the first quarter, Holdings Channel.com reports. The fund owned 6,279 shares of the biotechnology company's stock after selling 8,389 shares during the period. Cwm LLC's holdings in Axon Enterprise were worth $865,000 at the end of the most recent reporting period.
據Holdings Channel.com報道，Cwm LLC在第一季度將其持有的Axon Enterprise，Inc.(納斯達克代碼：Axon-Get Rating)的股票減持了57.2%。該基金在此期間出售了8,389股後，持有這家生物技術公司的6,279股股票。在最近一次報告期結束時，Cwm LLC在Axon Enterprise持有的股份價值86.5萬美元。
A number of other large investors have also bought and sold shares of AXON. Schonfeld Strategic Advisors LLC bought a new stake in Axon Enterprise during the third quarter valued at about $266,000. Diversified Trust Co grew its position in shares of Axon Enterprise by 30.1% during the fourth quarter. Diversified Trust Co now owns 3,196 shares of the biotechnology company's stock valued at $502,000 after purchasing an additional 740 shares in the last quarter. Exchange Traded Concepts LLC grew its position in shares of Axon Enterprise by 36.2% during the fourth quarter. Exchange Traded Concepts LLC now owns 674 shares of the biotechnology company's stock valued at $106,000 after purchasing an additional 179 shares in the last quarter. Koshinski Asset Management Inc. grew its position in shares of Axon Enterprise by 1,441.4% during the fourth quarter. Koshinski Asset Management Inc. now owns 447 shares of the biotechnology company's stock valued at $70,000 after purchasing an additional 418 shares in the last quarter. Finally, Stratos Wealth Partners LTD. grew its position in shares of Axon Enterprise by 7.9% during the fourth quarter. Stratos Wealth Partners LTD. now owns 4,538 shares of the biotechnology company's stock valued at $712,000 after purchasing an additional 331 shares in the last quarter. 72.06% of the stock is currently owned by institutional investors and hedge funds.
其他一些大型投資者也買賣了Axon的股票。Schonfeld Strategic Advisors LLC在第三季度購買了Axon Enterprise的新股份，價值約為266,000美元。多元化信託公司在第四季度將其在Axon Enterprise股票的頭寸增加了30.1%。多元化信託公司在上個季度又購買了740股後，現在擁有3,196股這家生物技術公司的股票，價值502,000美元。交易所交易概念有限責任公司在第四季度將其在Axon Enterprise股票的頭寸增加了36.2%。交易所交易的Concepts LLC現在擁有這家生物技術公司674股股票，價值10.6萬美元，此前在上個季度又購買了179股。Koshinski Asset Management Inc.在第四季度將其在Axon Enterprise的股票頭寸增加了1,441.4%。科辛斯基資產管理公司(Koshinski Asset Management Inc.)現在持有這家生物技術公司447股股票，價值7萬美元，該公司在上個季度又購買了418股。最後，Stratos Wealth Partners Ltd.在第四季度，其在Axon Enterprise的股票頭寸增加了7.9%。Stratos Wealth Partners Ltd.在上個季度又購買了331股後，現在擁有4538股這家生物技術公司的股票，價值71.2萬美元。72.06%的股票目前由機構投資者和對衝基金持有。
Shares of NASDAQ AXON opened at $94.03 on Thursday. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.43 and a quick ratio of 2.18. The company has a market cap of $6.68 billion, a P/E ratio of 180.83 and a beta of 0.61. Axon Enterprise, Inc. has a 1 year low of $82.49 and a 1 year high of $209.00. The firm has a 50-day simple moving average of $94.35 and a two-hundred day simple moving average of $118.84.
週四，納斯達克Axon的股價開盤報94.03美元。該公司的債務權益比為0.02，流動比率為2.43，速動比率為2.18。該公司市值為66.8億美元，市盈率為180.83，貝塔係數為0.61.Axon Enterprise，Inc.的一年低點為82.49美元，一年高位為209.00美元。該公司的50日簡單移動均線切入位在94.35美元，200日簡單移動均線切入位在118.84美元。
In other Axon Enterprise news, Director Mark W. Kroll sold 3,159 shares of the firm's stock in a transaction dated Wednesday, June 8th. The shares were sold at an average price of $102.82, for a total value of $324,808.38. Following the completion of the sale, the director now owns 13,691 shares of the company's stock, valued at $1,407,708.62. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 6.90% of the stock is owned by company insiders.
在Axon Enterprise的其他消息中，董事馬克·W·克羅爾在一筆日期為6月8日(星期三)的交易中出售了3,159股Axon Enterprise股票。這些股票的平均價格為102.82美元，總價值為324,808.38美元。出售完成後，董事現在擁有該公司13,691股股票，價值1,407,708.62美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的，可以通過美國證券交易委員會網站訪問該文件。6.90%的股份由公司內部人士持有。
AXON has been the subject of a number of research analyst reports. Credit Suisse Group initiated coverage on Axon Enterprise in a research report on Monday, May 9th. They set an "outperform" rating and a $169.00 price objective for the company. Morgan Stanley lowered Axon Enterprise from an "overweight" rating to an "equal weight" rating and set a $120.00 price objective for the company. in a research report on Monday, May 23rd. Northland Securities cut their price objective on Axon Enterprise from $180.00 to $130.00 in a research report on Thursday, May 12th. JMP Securities reiterated a "buy" rating and issued a $195.00 price target on shares of Axon Enterprise in a research report on Wednesday, June 1st. Finally, Robert W. Baird dropped their price target on Axon Enterprise from $145.00 to $125.00 in a research report on Wednesday, May 11th. One investment analyst has rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Axon Enterprise currently has a consensus rating of "Buy" and a consensus target price of $172.89.
Axon已經成為許多研究分析師報告的主題。瑞士信貸集團在5月9日星期一的一份研究報告中啟動了對Axon Enterprise的報道。他們為該公司設定了“跑贏大盤”的評級和169.00美元的目標股價。摩根士丹利將Axon Enterprise的評級從“增持”下調至“持平”，併為該公司設定了120.00美元的目標價.在5月23日星期一的一份研究報告中。Northland Securities在5月12日星期四的一份研究報告中將Axon Enterprise的目標價從180.00美元下調至130.00美元。摩根大通證券在6月1日週三的一份研究報告中重申了買入評級，並對Axon Enterprise的股票發佈了195.00美元的目標價。最後，羅伯特·W·貝爾德在5月11日星期三的一份研究報告中將Axon Enterprise的目標價從145.00美元下調至125.00美元。一名投資分析師對該股的評級為持有，8名分析師給出了買入評級，一名分析師給出了強烈的買入評級。根據MarketBeat的數據，Axon Enterprise目前的共識評級為買入，共識目標價為172.89美元。
Axon Enterprise Company Profile (Get Rating)
Axon企業公司簡介(獲取評級)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Axon Enterprise，Inc.在美國和國際上以泰瑟品牌開發、製造和銷售導電能源設備(CED)。它通過兩個部分運作，泰瑟槍和軟件和傳感器。該公司還提供硬件和基於雲的軟件解決方案，使執法部門能夠捕獲、安全存儲、管理、共享和分析視頻和其他數字證據。
See Also
另請參閲
- Get a free copy of the StockNews.com research report on Axon Enterprise (AXON)
- 3 Growth Stocks Trading at Value P/E's
- Capri Holdings Stock Looks Attractive For a Premium Retailer
- The Sell-Off In Kornit Digital May Set Up A 2nd Half Opportunity
- Phreesia Stock is a Healthcare IT Play
- Recession Resistant Grocery Outlet Holding Corp Quietly Sets New High
- 免費獲取StockNews.com關於Axon Enterprise(Axon)的研究報告
- 3只成長型股票的市盈率
- Capri Holdings的股票對高端零售商來説很有吸引力
- Kornit Digital的拋售可能帶來下半年的機會
- Phreesia Stock是醫療保健IT的一部劇
- 抗衰退雜貨直銷控股公司悄悄創新高
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating).
想看看還有哪些對衝基金持有Axon嗎？訪問HoldingsChannel.com獲取Axon Enterprise，Inc.(納斯達克：Axon-Get Rating)的最新13F備案和內幕交易信息。
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
接受Axon企業日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收Axon Enterprise和相關公司的最新新聞和分析師評級的每日簡明摘要。
譯文內容由第三人軟體翻譯。